Liver Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Jul 15, 2004; 10(14): 2014-2018
Published online Jul 15, 2004. doi: 10.3748/wjg.v10.i14.2014
Figure 1
Figure 1 Scatter plot to illustrate the distribution of serum VCAM-1 level (ng/mL) in healthy control subjects (n = 19), cir-rhosis subjects without HCC (n = 23), and HCC patients (n = 96).
Figure 2
Figure 2 Disease-free survival analysis of HCC patients segre-gated into low (≤ 467 ng/mL, n = 21) and high (> 467 ng/mL, n = 67) preoperative serum VCAM-1 levels (P = 0. 019).